CCR2 Orchestrates Preferential Homing and Therapeutic Efficacy of Gingival Mesenchymal Stem Cell-Derived Extracellular Vesicles in Rheumatoid Arthritis.

MedComm (2020) · 2026 · PMC12771584 · PMID 41503025

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Nevertheless, a trend toward improvement in xGvHD was observed with GMSC‐EVs treatment compared to GMSC treatment, although the difference did not reach statistical significance. Collectively, these xGvHD findings demonstrate that GMSC‐EVs retain immunomodulatory efficacy in a systemic inflammatory disease.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.